CCN1C(=O)[C@H]2CC[C@H]3/C(=N\O[C@@H](C)c4cn([C@H](CO)Cc5ccccc5)nn4)C[C@@H](O)[C@@H](O)[C@@H]3[C@@H]2C1=O
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?